Lorillard Inc

Lorillard — 2014 CAGNY Conference

71 slides from Lorillard's conference presentation, Feb 18, 2014

  1. Slide 1: Lorillard 2014 CAGNY Conference

    Lorillard 2014 CAGNY Conference Newport Cigarettes Newport Cigarettes blu February 18, 2014

  2. Slide 2: Murray S. Kessler, Chairman, President and CEO

    Murray S. Kessler Chairman, President and Chief Executive Officer

  3. Slide 3: Agenda

    Agenda Lorillard Business & Opportunities Review Regulatory Update & Assessment Financial Update Summary & Q&A Murray Kessler Chairman, President & CEO Neil Wilcox SVP, Chief Compliance Officer David Taylor EVP, Finance & CFO All

  4. Slide 4: Safe Harbor Disclaimer

    Safe Harbor Disclaimer You are cautioned that certain statements made in this presentation are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may project, indicate or

  5. Slide 5: Regulation G Compliance

    Regulation G Compliance You are also reminded that during this presentation, certain non-GAAP financial measures, such as Adjusted Earnings Per Share may be discussed. These measures should not be considered an alternative to net income, or any other measure of financial performance or liquidity pre

  6. Slide 6: Lorillard Has Built Very Strong Brands Through a Long-Term Focus

    Lorillard Has Built Very Strong Brands Through a Long-Term Focus The #2 U.S. Cigarette Brand - Newport® The #1 U.S. Menthol Brand - Newport The #1 U.S. electronic cigarette – blu eCigs® – Newly-acquired international e-cigarette business - SKYCIG® Newport Cigarettes Blu CGS Source: MSA, Inc. retail

  7. Slide 7: In Cigarettes, Lorillard has Gained Market Share For Eleven Consecutive Years

    In Cigarettes, Lorillard has Gained Market Share For Eleven Consecutive Years Lorillard Retail Market Share of U.S. Cigarettes 16% 14% 12% 10% 8% 6% 4% 2% 0% 8.7% 9.0% 9.2% 9.6% 10.0% 10.4% 11.0% 11.8% 12.9% 14.1% 14.4% 14.9% 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Newport Total

  8. Slide 8: Lorillard's Cigarette Volume Has Dramatically Outperformed Peer Companies

    Lorillard’s Cigarette Volume Has Dramatically Outperformed Peer Companies over the Long-Term Volume Change (billions of cigarettes) 2005 - 2013 +4.1 Altria Reynolds Lorillard -43 -56 Source: MSA, Inc. domestic shipment data

  9. Slide 9: And Lorillard Has Been Consistently Rewarding Shareholders with Superior Returns

    And Lorillard Has Been Consistently Rewarding Shareholders with Superior Returns over the Long-Term Prices Indexed to 100 600 500 400 300 200 100 0 +443.0% +63.5% Jan-02 Jan-03 Jan-04 Jan-05 Jan-06 Jan-07 Jan-08 Jan-09 Jan-10 Jan-11 Jan-12 Jan-13 LO S&P 500 Source: Bloomberg. From Carolina Group IPO

  10. Slide 10: Ultimately Contributing To Significant Increases In Shareholder Value

    Ultimately Contributing To Significant Increases In Shareholder Value Approximately $9 billion of value creation just since 2008 Stock Price $25.5 P/E Ratio 14.9 Enterprise Value (B) $12.2 Stock Price $50.7 P/E Ratio 16.2 Enterprise Value (B) $20.6 2008 2009 2010 2011 2012 2013 Source: Bloomberg. Fr

  11. Slide 11: Key Elements of Lorillard's Consistent Success Over The Long-Term

    Key Elements of Lorillard’s Consistent Success Over The Long-Term 1. Focus on the Core 2. A Passion for Brand-Building 3. Lean Cost Structure Mentality 4. Pursuing Close-in Adjacencies without Distracting or Detracting from the Core Menthol Business 5. Shareholder-Friendly Policies 6. Recognition th

  12. Slide 12: Newport is our Core Flagship Brand

    Newport is our Core Flagship Brand Newport Non-Mentol Box Newport Non-Mentol CIGARETTES Newport BOX 100s CIGARETTES Approximately $6 Billion in Net Sales Over $10 Billion in Retail Sales Brand is larger at U.S. Retail than Coke, Tylenol Two of the Top 5 Cigarette SKUs in the U.S.

  13. Slide 13: Over 75% of Sales and 85% of Profits Come from Newport Full Flavor Menthol

    Over 75% of Sales and 85% of Profits Come from Newport Full Flavor Menthol Cigarettes Lorillard 2013 Net Sales & Operating Profit Newport Net Sales Newport Profit Source: Lorillard.

  14. Slide 14: Newport Full-Flavor Menthol in Core Geographies Is Job #1

    Newport Full-Flavor Menthol in Core Geographies Is Job #1 Premium Full-Flavor Menthol, Core States 100% All Other All Other All Other All Other 80% 60% 40% Newport Newport Newport Newport 20% 0% FF Prem Menthol Rest of Industry -1.6% -5.0% Newport Share of Premium Full-Flavor Menthol Core States 74%

  15. Slide 15: As is the Discipline to Maintain a Narrow Product Line

    As is the Discipline to Maintain a Narrow Product Line Cigarette Product Offerings by Company Other Maverick Newport Lorillard Other L&M Basic Marlboro Altria Other Monarch Doral GPC Pall Mall Camel Reynolds Source: MSA, Inc. retail shipment database - based on products sold in Q4 2013.

  16. Slide 16: This Focus Allows for Greater Operational Efficiency And Enhanced Profitability

    This Focus Allows for Greater Operational Efficiency And Enhanced Profitability Long Manufacturing Runs Sales Force Focus Consistency within Retail Shelf Space Focused Brand Management

  17. Slide 17: Key Elements of Lorillard's Consistent Success Over The Long-Term

    Key Elements of Lorillard’s Consistent Success Over The Long-Term 1. Focus on the Core 2. A Passion for Brand-Building 3. Lean Cost Structure Mentality 4. Pursuing Close-in Adjacencies without Distracting or Detracting from the Core Menthol Business 5. Shareholder-Friendly Policies 6. Recognition th

  18. Slide 18: Brand-Building is Also a Top Priority

    Brand-Building is Also a Top Priority Brand-Building Initiatives Advertising Product Newport pleasure! Consistent 40-year campaign Distinctive & recognizable Proven messaging Newport BOX 100s Newport CIGARETTES Iconic brand Consumer preferred Unique taste profile Merchandising 275,000+ retail stores

  19. Slide 19: Leading to Strong Brand Equity as Measured By A High Net Promoter Score

    Leading to Strong Brand Equity as Measured By A High Net Promoter Score NPS Scores 61% 53% 51% 30% 27% 23% 19% 7% Newport Cigars Average Cigarettes Average Chewing Gum Average Breath Mint Average Overall CPG Average Coffee Average Beverage Average Source: 2013 Lorillard Adult Consumer Survey and res

  20. Slide 20: Discounting is Avoided as Much as Possible

    Discounting is Avoided as Much as Possible Percentage of 2013 Menthol Volume Sold at Full Price* 100% 97% 80% 63% 60% 54% 40% Newport #2 Menthol Brand #3 Menthol Brand * Source: MSA, Inc. retail shipment database. Full price is defined as within 50 cents per pack of the most common retail price of t

  21. Slide 21: All of this Results in Newport Commanding a Premium Price

    All of this Results in Newport Commanding a Premium Price Average Retail Price Per Pack of Major Cigarette Brands $ 6.45 $ 6.52 $6.50 $6.36 Newport $6.25 $6.28 $6.24 Marlboro $6.00 Camel $5.64 $5.62 $5.60 $5.50 2011 2012 2013 Source: Nielsen Convenience store scanner data, 2011 - 2013

  22. Slide 22: And Most Importantly, Newport Has Become More and More Relevant!

    And Most Importantly, Newport Has Become More and More Relevant! Newport market share among total adult smokers vs. 18-25 25% 22.5% 22.6% 20.8% 20% 19.3% 18.9% 19.9% 15.3% 15% 13.3% 14.1% 12.6% 12.1% 11.6% Total 10% 18-25 5% 0% 2007 2008 2009 2010 2011 2012 Source: National Survey on Drug Use and He

  23. Slide 23: Key Elements of Lorillard's Consistent Success Over The Long-Term

    Key Elements of Lorillard’s Consistent Success Over The Long-Term 1. Focus on the Core 2. A Passion for Brand-Building 3. Lean Cost Structure Mentality 4. Pursuing Close-in Adjacencies without Distracting or Detracting from the Core Menthol Business 5. Shareholder-Friendly Policies 6. Recognition th

  24. Slide 24: A Lean Cost Structure is Part of Lorillard's DNA

    A Lean Cost Structure is Part of Lorillard’s DNA 2013 Controllable Costs Per Pack* $0.65 $0.57 $0.55 Lorillard Altria RJR 2013 Adjusted Operating Income Per Pack For Cigarette/Smokeable segments $1.01 $0.92 $0.77 Lorillard Altria RJR Source: Morgan Stanley Research, 2/12/2014 Source: Company filings

  25. Slide 25: Key Elements of Lorillard's Consistent Success Over The Long-Term

    Key Elements of Lorillard’s Consistent Success Over The Long-Term 1. Focus on the Core 2. A Passion for Brand-Building 3. Lean Cost Structure Mentality 4. Pursuing Close-in Adjacencies without Distracting or Detracting from the Core Menthol Business 5. Shareholder-Friendly Policies 6. Recognition th

  26. Slide 26: Four Key Priorities for Adjacency Expansion

    Four Key Priorities for Adjacency Expansion 1234 Build Newport Share in non-core geographies Invest to breakthrough in non-menthol Strengthen our less than full-flavor menthol franchise Opportunistically pursue non-cigarette adjacencies Lorillard

  27. Slide 27: Geographic Expansion of Promotions and Product Line Have Been Successful

    Geographic Expansion of Promotions and Product Line Have Been Successful Results from geographic expansion strategy in the non-core Volume Trends 5.5% Newport -4.9% 18.6% -1.1% Total Lorillard Pre Post Market Share 5.0% 4.3% 7.3% 5.5% Pre Post Source: MSA, Inc. retail shipment database. Pre period i

  28. Slide 28: As Has Lorillard's Entry into Non-Menthol, with Newport Red

    As Has Lorillard’s Entry into Non-Menthol, with Newport Red 46 B units Newport RJR Altria 100% 80% 60% 40% 20% 0% 2013 Premium Non-Menthol Full Flavor Units by Brand Newport NON-MENTHOL BOX Newport NON-MENTHOL CIGARETTES 0.9% retail market share 2.4 billion units in 2013 Pricing up more than 35% sin

  29. Slide 29: As Has Our Initial Effort to Strengthen Non-Full Flavor Menthol

    As Has Our Initial Effort to Strengthen Non-Full Flavor Menthol with Smooth Select 17 B units 100% Newport 80% RJR 60% 40% Altria 20% 0% 2013 Premium Menthol Non-Full Flavor Units by Brand Newport MENTHOL GOLD BOX Newport MENTHOL GOLD CIGARETTES Newport SMOOTH SELECT MENTHOL Only 11% share of catego

  30. Slide 30: Non-Menthol Gold Represents a Large Opportunity

    Non-Menthol Gold Represents a Large Opportunity, Albeit Off to a Slow Start. 84 B units 100% Other RJR 80% 60% 40% Altria 20% 0% 2013 Premium Non-Menthol Non-Full Flavor Units by Brand Shipments began October 2013 Consumer-preferred taste Consumer-preferred packaging Priced in-line with Newport Red

  31. Slide 31: Our Entry into e-Cigarettes Has Been Another Success

    Our Entry into e-Cigarettes Has Been Another Success For the Company Rise from the Ashes blu TM ELECTRONIC CIGARETTES blu National retail roll-out –136,000+ outlets currently National TV and print advertising campaign ($40 MM 2013 marketing spend) Product enhancements & quality controls Increased ma

  32. Slide 32: Brand-Building is Also the Top Priority in e-Cigarettes

    Brand-Building is Also the Top Priority in e-Cigarettes Stephen Dorff Jenny McCarthy Lorillard

  33. Slide 33: 2013 Event Marketing Recap

    2013_Event_marketing_recap_-_Internal_Use_Only_ blu™ eCIGS ELECTRONIC CIGARETTES NOT FOR SALE TO MINORS blu eCigs® electronic cigarettes are not a smoking cessation product and have not been evealuated by the Food and Drug Administration, nor are they intended to treat, prevent or cure any disease o

  34. Slide 34: These Brand-Building Efforts Have Quickly Built Strong Brand Dynamics

    These Brand-Building Efforts Have Quickly Built Strong Brand Dynamics Awareness – Have You Heard of blu eCigs? 57% 82% Q1 2013 Q3 2013 Incidence of use among adult cigarette smokers eCigs MST Snus 47% 24% 16% 24% 9% 5% 15% 5% 3% Ever Tried Used in the Past Used in the Past 3 Months 7 Days Sources: b

  35. Slide 35: And Have Made blu the Clear e-Cig Category Leader!

    And Have Made blu the Clear e-Cig Category Leader! Quarterly blu eCigs Retail Market Share 40%+ Market Share ~136,000 Retail Outlets 50% 48% 40% ~10% Market Share* 34% 30% ~12,000 Retail Outlets 20% 15%* 10%* 10% 0% Q2 2012 Q3 2012 Q4 2012 Q4 2013 EPS Accretive in Year 1 Source: MSA, Inc. retail shi

  36. Slide 36: We Also Completed Another e-Cigarette Acquisition

    We Also Completed Another e-Cigarette Acquisition – The First Step in Global Expansion Demonstrated track record of bringing innovative products to market Provides platform for further geographic expansion Establishes Lorillard as a global leader in tobacco harm reduction Lorillard

  37. Slide 37: It is Our Goal to Build blu eCigs into a Global Brand

    It is Our Goal to Build blu eCigs into a Global Brand Re-branding of SKYCIG to blu eCigs Transitioning of the brands in the UK blu eCigs brand to be expanded into Western Europe Requires incremental investment blu by SKYCIG Lorillard

  38. Slide 38: Key Elements of Lorillard's Consistent Success Over The Long-Term

    Key Elements of Lorillard’s Consistent Success Over The Long-Term 1. Focus on the Core 2. A Passion for Brand-Building 3. Lean Cost Structure Mentality 4. Pursuing Close-in Adjacencies without Distracting or Detracting from the Core Menthol Business 5. Shareholder-Friendly Policies 6. Recognition th

  39. Slide 39: Rewarding Shareholders is Always Top-of-Mind

    Rewarding Shareholders is Always Top-of-Mind Focused on generating cash flow 70-75% dividend payout ratio Dividend growth tied to earnings Modest capital spending needs Excess cash from operations targeted to share repurchases Transparency in financial reporting, although no guidance Lorillard

  40. Slide 40: Resulting in Significant Cash Returns to Shareholders

    Resulting in Significant Cash Returns to Shareholders Annualized Dividend Per Share $3.00 +79% $2.20 $2.00 $2.07 $1.73 $1.50 $1.33 $1.00 $1.23 Q3 2008 Q3 2009 Q3 2010 Q3 2011 Q3 2012 Q3 2013 70-75% Dividend Payout Policy Total Shares Outstanding millions -30% Q2 2008 Q4 2013 $5 Billion in Share Repu

  41. Slide 41: Key Elements of Lorillard's Consistent Success Over The Long-Term

    Key Elements of Lorillard’s Consistent Success Over The Long-Term 1. Focus on the Core 2. A Passion for Brand-Building 3. Lean Cost Structure Mentality 4. Pursuing Close-in Adjacencies without Distracting or Detracting from the Core Menthol Business 5. Shareholder-Friendly Policies 6. Recognition th

  42. Slide 42: People Make the Difference

    People Make the Difference Percentage of Critical Executives Filled from Inside / Outside of Company Inside Outside Of the 42 most critical Lorillard roles identified, 45% have been filled from within and 55% have been new hires. Lorillard Net Promoter Scores Benchmarks 65% 32% 23% 4% -16% Low Avera

  43. Slide 43: Compensation and Governance Philosophies Align With Shareholder Interests

    Compensation and Governance Philosophies Align With Shareholder Interests Short-Term 40% operating profit 40% Newport market share 20% individual goals Long-Term 50-80% of compensation in shares with 3-year vesting Tied to EPS targets Compensation policies coupled with strong governance Declassified

  44. Slide 44: Summary

    Summary Focus on the Core Shareholder- Friendly Policies A Passion For Brand-Building Double-Digit Shareholder Return* Pursuing Close-In Adjacencies Without Distractions Lean Cost Structure People Make a Difference * As measured by annual EPS growth plus dividend yield. Lorillard

  45. Slide 45: Regulatory Update & Assessment

    Regulatory Update & Assessment Neil Wilcox SVP, Chief Compliance Officer Lorillard

  46. Slide 46: Two Regulatory Issues That Some Worry Can Affect Lorillard's Long-Term Success

    Two Regulatory Issues That Some Worry Can Affect Lorillard’s Long-Term Success 1. Menthol’s potential impact on public health 2. Deeming regulations for electronic cigarettes CTP is required to navigate within FDA’s regulatory framework CTP is committed to “Follow-the-Science” Mitch Zeller, JD Altho

  47. Slide 47: What's The Current Status of Menthol?

    What’s The Current Status of Menthol? On July 24, 2013 -FDA published two documents: PSE (Preliminary Scientific Evaluation) on menthol, and ANPRM (Advanced Notice of Proposed Rulemaking), As of January 24, 2014 FDA received 174,796 comments to the docket Every comment submitted to the menthol docke

  48. Slide 48: Lorillard's View on CTP's Menthol Assessment

    Lorillard’s View on CTP’s Menthol Assessment Ø FDA’s PSE is Fundamentally Flawed – Lack of transparency in FDA’s selection and weighting of studies – FDA’s conclusions often based on strained interpretations of data and not supported by suitable evidence – FDA inappropriately uses “association” inst

  49. Slide 49: What's the Likelihood of FDA Action?

    What’s the Likelihood of FDA Action? According to Mitch Zeller, “FDA has met its congressional obligations as required by the TCA: - TPSAC completed report on menthol - PSE & ANPRM published - Completing these requirements does not imply future rule-making and FDA is not obligated to take any action

  50. Slide 50: Lorillard Agrees with Comments from the CTP Director

    Lorillard Agrees with Comments from the CTP Director “It would be inappropriate for me to prejudge any potential action that we could take other than to say we’re in information-seeking mode.” “We want more evidence, more information as we ponder any potential action that we could take.” Mitch Zelle

  51. Slide 51: Lorillard's Position on Menthol is Based on Science

    Lorillard’s Position on Menthol is Based on Science Scientific evidence does not support a finding that a product standard related to menthol would be “appropriate for public health” We continue to believe that the science does not provide a basis for regulating menthol cigarettes differently from n

  52. Slide 52: FDA's Deeming Regulations for e-Cigarettes

    FDA’s Deeming Regulations for e-Cigarettes Lorillard intends to hold regulators to science-based decisions • Lorillard supports reasonable regulations for e-cigs including: – Minimum age of purchase laws restricting sales to minors – Product quality and safety standards – Science-based regulation -

  53. Slide 53: Lorillard is Well Positioned for Opportunities!

    Lorillard is Well Positioned for Opportunities! Lorillard has FDA expertise as demonstrated by obtaining the only two authorizations for SE cigarette products FDA is mandated to “follow-the-science” when justifying regulations – the science is simply not there for regulating menthol in cigarettes E-

  54. Slide 54: Summary

    Summary Excellent communications have been established with CTP We have received the first and only SE Orders for new cigarette products We look forward to working with the FDA on e-cig regulations We have communicated our views on menthol in cigarettes to CTP – supported by robust science Lorillard

  55. Slide 55: Financial Update

    Financial Update David Taylor EVP, Finance and Planning & CFO

  56. Slide 56: Lorillard Formula for Success is Unchanged

    Lorillard Formula for Success is Unchanged Industry Leading Fundamentals Lean Cost Structure Focus on Returning Cash to Shareholders Consistent Delivery of a Double Digit Total Shareholder Return Over the Long-Term * Double-digit shareholder return as measured by EPS growth and the dividend yield.

  57. Slide 57: Driving a Consistent Track Record of Superior Financial Results

    Driving a Consistent Track Record of Superior Financial Results Net Sales (ex-FET) Billions $6.0 $5.0 $4.0 $3.0 $2.0 $1.0 $0.0 3.49 3.69 4.05 4.45 4.64 4.97 2008 2009 2010 2011 2012 2013 + 7.3% Operating Income* Billions $2.5 $2.0 $1.5 $1.0 $0.5 $0.0 1.42 1.54 1.73 1.87 1.88 2.03 2008 2009 2010 2011

  58. Slide 58: Allowing The Company to Return Significant Cash to Shareholders

    Allowing The Company to Return Significant Cash to Shareholders Cumulative Cash Returned (millions) $10,000 $7,500 $5,000 $2,500 $0 $8,928 $7,310 $5,925 $3,615 $2,254 $713 $1,310 $944 $2,026 $1,589 $3,613 $2,312 $4,191 $3,119 $4,986 $3,942 2008 2009 2010 2011 2012 2013 Dividends Buybacks $9 Billion

  59. Slide 59: 2013 Was a Continuation Of Lorillard's Industry-Leading Fundamentals

    2013 Was a Continuation Of Lorillard’s Industry-Leading Fundamentals Lorillard 2013 performance versus year ago 14% 12% 10.6% 10% 7.2% 7.8% 8% 6% E.P.S.* Operating 4% Net Sales Income* 2% (ex-FET) 0% 2013 Change * Adjusted results. See Appendix A for further discussion of adjustments. Source: Compan

  60. Slide 60: Capital Needs

    Capital Needs Capital Expenditures ~ $70 - $80 million per year Other – blu eCigs acquisition $135 million in 2012; SKYCIG acquisition in 2013 Working capital investments to fund growth Capital Expenditures $100 $75 $50 $25 $0 $44 $51 $40 $56 $74 $62 2008 2009 2010 2011 2012 2013 Source: Lorillard f

  61. Slide 61: Capital Returns - Dividends

    Capital Returns - Dividends Dividend Policy – 70% - 75% of Earnings Annualized Dividend Rate $2.50 $1.50 $0.50 $1.23 $1.33 $1.50 $1.73 $2.07 $2.20 Q3 2008 Q3 2009 Q3 2010 Q1 2011 Q1 2012 Q1 2013 Source: Lorillard filings.

  62. Slide 62: Capital Returns – Share Repurchases

    Capital Returns – Share Repurchases Share repurchases continue to be attractive uses of cash $3.0 $8.9 Billion Total Cash Returned to Shareholders Returned $2.5 Share Repurchases $2.0 Dividends $1.5 $1,586 $795 $910 $578 $1.0 $716 $0.5 $400 $723 $807 $823 $631 $645 $313 $0.0 2008 2009 2010 2011 2012

  63. Slide 63: Leverage

    Leverage Target is 1.5x – 2.0x debt to EBITDA Not likely to change without change in current environment Protect investment grade ratings Currently at 1.7x Gross Debt $4,000 $3,000 $2,000 $1,000 $0 $750 $1,750 $2,500 $3,000 $3,500 2009 2010 2011 2012 2013 Weighted average interest rate 4.95% Source:

  64. Slide 64: Financial Guidance Scenarios

    Financial Guidance Scenarios Potential Long-Term EPS Growth Rate Scenarios – All Delivering Double-Digit Shareholder Return* Mid-Single Digit Heightened promotion environment No new products Share repurchases from free cash flow Limited contribution from blu eCigs High-Single Digit Normal historical

  65. Slide 65: Financial Outlook

    Financial Outlook Some positive factors in place: Share repurchase program increased following $500 million debt issuance in May 2013 Partial settlement of NPM dispute provides liquidity and some continuing earnings benefit Obligations for the Federal Assessment for Tobacco Growers will end in 2014

  66. Slide 66: Summary

    Summary All elements are in place to continue our history of superior financial results Positioned to deliver robust earnings growth We remain committed to rewarding shareholders with cash returns

  67. Slide 67: Questions

    Lorillard Questions Murray S. Kessler Chairman, President and Chief Executive Officer David H. Taylor Executive Vice President and Chief Financial Officer Neil L. Wilcox, DVM, MPH Senior Vice President and Chief Compliance Officer

  68. Slide 68: Appendix A

    Appendix A Regulation G Reconciliations Reconciliation of Reported (GAAP) to Adjusted (Non-GAAP) Results (Amounts in millions, except per share data) (Unaudited) Year ended December 31, 2011 Reported (GAAP) results GAAP results include the following: 1) Tobacco settlement expense impact of RAI mark-

  69. Slide 69: Appendix A (cont.)

    Appendix A (cont.) Regulation G Reconciliations Reconciliation of Reported (GAAP) to Adjusted (Non-GAAP) Results (Amounts in millions, except per share data) (Unaudited) Year Ended December 31, 2013 E-Cigarette Operating Diluted Segment Income EPS Operating Income Reported (GAAP) results $2,074 $3.1

  70. Slide 70: Appendix A (cont.) Leverage Ratios

    Appendix A (cont.) Regulation G Reconciliations Leverage Ratios 2010 2011 2012 2013 Adjusted operating income $1,725 $1,867 $1,883 $2,030 Depreciation and amortization Earnings before interest, taxes, depreciation and amortization (B) $1,760 $1,904 $1,922 $2,080 Long-term debt $1,769 $2,595 $3,111 $

  71. Slide 71: Lorillard

    Lorrilard

Lorillard — 2014 CAGNY Conference on 6ix